QUESTIONNAIRE AND FOLLOW-UP COMPUTER PROGRAM FOR PATIENTS WITH ENDOMETRIAL CANCER

Authors

  • Iztok Takač Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor
  • Darja Arko Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor
  • Robert Bali Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor
  • Nina Čas Sikošek Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor
  • Borut Gorišek Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor
  • Dunja Zukanović Oddelek za ginekološko onkologijo in onkologijo dojk Klinični oddelek za ginekologijo in perinatologijo Splošna bolnišnica Maribor Ljubljanska 5 2101 Maribor

DOI:

https://doi.org/10.6016/ZdravVestn.2309

Keywords:

endometrial cancer, questionnaire, computer program

Abstract

Background. Endometrial cancer is the most frequent genital malignancy among women in Slovenia. During diagnostic and treatment procedures as well as follow-up of endometrial cancer patients after treatment, a lot of data is generated. However, its amount frequently disable the transparency and instant availability.

Methods. An questionnaire for following of endometrial cancer patients has been compiled. Beside general information regarding the patient, diagnosis and treatment, it also includes the case history, data regarding clinical, ultrasonographic and preoperative examinations, surgery, histologic findings and follow-up after termination of treatment. A user-friendly computer program was developed for recording and processing of all available data collected during the diagnostic and treatment procedures.

Results. Questionnaire and computer program have been in use for three years and have found they are very useful in follow-up of patients with endometrial cancer. Data are collected at one site, transparent and always available. Statistical analysis of collected data can be performed by computer.

Conclusions. The aim of this uniform questionnaire and computer program is a concurrent, radical and simplified collecting and processing of data at each center dealing with the treatment of endometrial cancer.

Downloads

Download data is not yet available.

References

Gusberg SB. Diagnosis and principles of treatment of cancer of the endometrium. In: Gusberg SB, Shingleton HM, Deppe G eds. Female genital cancer. New York: Churchill, 1988: 337–60.

Cowan BD, Morrison JC. Management of abnormal genital bleeding in girls and women. N Engl J Med 1991; 324: 1710–5.

Golouh R, Lindtner J, Pompe-Kirn V et al. (eds.). Incidenca raka v Sloveniji 1999. Ljubljana: Onkološki inštitut, 2002: 30–44.

Stržinar V. Rak materničnega telesa. In: Fras AP ed. Onkologija. Ljubljana; Onkološki inštitut v Ljubljani, 1994: 300–4.

Pajntar M, Leskošek B. Rezultati projekta: »Kakovost v zdravstvu Slovenije«. Zdrav Vestn 2002; 71: 765–71.

Gehrig PA, Van Le L, Fowler WC. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 2003; 13: 212–5.

Fras AP. Brahiterapija pri raku ženskih spolovil. In: Fras AP ed. Onkologija. Ljubljana; Onkološki inštitut v Ljubljani, 1994: 318–21.

Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer 1997; 79: 320–7.

Chambers JT, Rutherford TJ, Schwartz PE, Carcangiu ML, Chambers SK, Baker L. A pilot study of topotecan in the treatment of serous carcinoma of the uterus. Int J Gynecol Cancer 2003; 13: 216–22.

Lampe B, Kürzl R, Hantschmann P. Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage. Int J Gynecol Pathol 1995; 14: 2–6.

Hachisuga T, Kawarabayashi T, Iwasaka T, Sugimori H, Kamura T, Tsuneyoshi M. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas. Gynecol Oncol 1997; 65: 115–20.

Matthews RP, Hutchinson-Colas J, Maiman M et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol 1997; 65: 206–12.

Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64: 411–7.

Reich O, Winter R, Pickel H, Tamussino K, Haas J, Petru E. Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int J Gynecol Cancer 1996; 6: 445–7.

Creasman WT, Boronow RC, Morrow CP, Di Saia PJ, Blessing J. Adenocarcinoma of the endometrium: Its metastatic lymph node potential. Gynecol Oncol 1976; 4: 239–43.

Calais G, Descamps P, Vitu L et al. Is lymphadenectomy useful in the treatment of endometrial carcinoma? Gynecol Oncol 1990; 38: 71–5.

Lanciano RM, Greven KM. Adjuvant treatment for endometrial cancer: Who needs it? Gynecol Oncol 1995; 57: 135–7.

Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K. Low risk endometrial cancer: A study of pelvic lymph node metastasis. Int J Gynecol Cancer 2003; 13: 38–41.

Issue

Section

Professional Article

How to Cite

1.
QUESTIONNAIRE AND FOLLOW-UP COMPUTER PROGRAM FOR PATIENTS WITH ENDOMETRIAL CANCER. ZdravVestn [Internet]. 2004 Apr. 25 [cited 2024 Nov. 2];73(4). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2309

Most read articles by the same author(s)

1 2 3 > >>